
Job-ID: 63998
Location: Wien, AUT
Job Level: Entry Level
Category: Production
Employment Type: Permanent position
Become part of a vital chain and contribute to our common goal of making people's lives better. Octapharma is one of the largest human protein manufacturers in the world, developing and producing medicines sourced from human plasma and human cell lines. We are a privately-owned company, where the warmth of family meets the scale of a global organisation.
With over 1700 employees, the Octapharma site in Vienna is the largest production site, and successful research and development location.
As Group Expert - Quality Management IT within the MSAT / Track & Trace team, you will play a key role in managing IT compliance across this area. You will provide expert guidance and support projects and changes within the Track & Trace / MSAT environment. Working closely with our IT teams, you will also act as a Business Partner to IT. Ensuring the required quality of our continuously evolving IT systems will be a key focus of this role.
Join us in shaping our vision of providing new health solutions advancing human life.
Enjoy these attractive benefits! You can find all offers here: Benefits
The minimum gross salary according to the collective agreement (chemical industry) is EUR 4,355.55 based on 38 hours per week (full-time). As we strive to offer a salary that reflects your individual profile and qualifications, there is a willingness to pay above the minimum salary.
We live diversity and stand for equal opportunities as an employer! We therefore look forward to receiving your application - regardless of age, gender, origin, sexual orientation, and religion.
Do you have any questions? Then get in touch with your contact person.
Larissa Amling
Octapharma Pharmazeutika Produktionsges.m.b.H.
Oberlaaer Straße 235, 1100 Wien
T: +43 664 789 53 728
Visit our website Octapharma Career and follow us daily on LinkedIn.
Headquartered in Lachen, Switzerland, Octapharma is one of the largest human protein manufacturers in the world, developing and producing plasma-derived and recombinant medicines.
Octapharma employs more than 11,000 people worldwide to support the treatment of patients in 120 countries with products in three therapeutic areas: Immunotherapy, Haematology, and Critical Care.
Octapharma has seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany and Sweden, and operates more than 200 plasma donation centres across Europe and the US.